The Valley Desk

NCT01452815 · Interventional trial

Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis

Overall registry status Completed

Phase 2

Conditions Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Gastroparesis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov